Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort

Poor outcome of HIV-infected patients with plasmablastic lymphoma

(2013) Philipp Schommers et al.   AIDS

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

(2013) S. K. Barta et al.   BLOOD

Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era

(2013) S. Gopal et al.   JNCI-Journal of the National Cancer Institute

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkittʼs lymphoma

(2010) Silvia Montoto et al.   AIDS

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

(2010) K. Dunleavy et al.   BLOOD

Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States

(2010) Edgar P Simard et al.   CANCER

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

(2009)   AIDS

Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial

(2008) Josep-Maria Ribera et al.   BRITISH JOURNAL OF HAEMATOLOGY